Tudorza Pressair (aclidinium bromide inhalation powder)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
CONTRAINDICATIONS
The use of TUDORZA PRESSAIR is contraindicated in the following conditions:
Severe hypersensitivity...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Aclidinium Bromide | Drugs & Pharmacology